Inactive Instrument

Press Releases OASA PHARADR Nasdaq

Equities

US67421W1099

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Notice of Annual General Meeting in Vivesto AB	Apr. 23	AQ
Vivesto to hold live-streamed Paccal Vet R&D Update on March 26	Mar. 19	AQ
Vivesto doses first patient in its clinical Paccal Vet trial	Mar. 07	AQ
Vivesto's international patent application for XR-18 receives positive decision	Jan. 30	AQ
Vivesto’s US clinical Paccal Vet trial receives approval to start patient recruitment	Dec. 28	AQ
Vivesto’s Paccal Vet granted FDA MUMS designation	Dec. 22	AQ
Vivesto makes impairment charge following withdrawal of European market authorizations for Apealea	Dec. 22	AQ
Vivesto reports positive preclinical data supporting continued development of Cantrixil	Dec. 19	AQ
Nomination Committee appointed for the 2024 Annual General Meeting in Vivesto	Nov. 23	AQ
Vivesto and Elevar sign agreement ending Apealea® partnership	Nov. 23	AQ
Interim report for the period January 1, 2023 – September 30, 2023	Nov. 16	AQ
Vivesto focuses its project portfolio and introduces cost-saving measures	23-10-25	AQ
Delisting of Vivesto’s shares from Frankfurt Stock Exchange effective as of 15 September 2023	23-09-15	AQ
Interim report for the period January 1, 2023 – June 30, 2023	23-08-24	AQ
Vivesto announces early termination of patient enrollment in the investigator-initiated Phase 1b Docetaxel micellar study	23-08-04	AQ
Vivesto announces positive Paccal Vet FDA pre-submission meeting	23-06-16	AQ
Vivesto : Presentation Erik Penser Bank Presentation	23-05-26	PU
Report from Annual General Meeting in Vivesto AB	23-05-25	AQ
Interim report for the period January 2023 – March 2023	23-05-25	AQ
Vivesto : Annual General Meeting 2023	23-05-23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases OASA PHARADR Nasdaq

Equities

US67421W1099

Press Releases

Filters